Table 3-2.
Mamaternal outcomes of SARS-CoV-2 positive and SARS-CoV-2 negative pregnant women
| Research | Preterm birth (PB) | P-Value | Delivery type | P-Value | Maternal Death | P-Value | |||
|---|---|---|---|---|---|---|---|---|---|
| Vaginal delivery | P-Value | cesarean delivery | P-Value | ||||||
| Pirjani R;2020 [16] | — | 0.064/0.689 | — | — | — | 0.030/0.024# | — | — | — |
| Adhikari EH;2020 [17] |
COVID-19: 27/245 (11%) No COVID-19:328/3035 (11%) |
0.92 |
COVID-19:174/245 (71%) No COVID-19:1975/3035 (65%) |
0.09 |
COVID-19: 65/245 (27%) No COVID-19:1011/3035 (33%) |
0.03* | — | — | — |
| Alipour Z;2021 [15] |
COVID-19: 25/53 (47.2%) No COVID-19: 18/135 (13.3%) |
0.000# |
COVID-19: 20/53 (37.7%) No COVID-19:47/135 (34.8%) |
— |
COVID-19: 9/53 (17.0%) No COVID-19: 70/135 (51.9%) |
0.22/0.04* | — |
COVID-19: 4/133 (3.0%) No COVID-19: 0/165(0) |
0.03* |
| Binte Masud S;2021 [14] |
COVID-19: 37/70 (52.9%) No COVID-19: 42/140 (30.0%) |
0.001# |
COVID-19: 20/70 (28.6%) No COVID-19:81/140 (57.9%) |
— |
COVID-19: 50/70 (71.4%) No COVID-19: 59/140 (42.1%) |
— | < 0.001# | — | — |
| Gupta P;2021 [20] |
COVID-19: 31/108 (28.3%) No COVID-19: 447/3057 (14.6%) |
0.0001# |
COVID-19: 45/108(41.6%) No COVID-19: 2143/3057 (70.1%) |
< 0.0001# |
COVID-19: 63/108(58.3%) No COVID-19:914/3057 (29.8%) |
< 0.0001# | — |
COVID-19: 1/108 (0.9%) No COVID-19:7/3057 (0.22%) |
0.1586 |
| Gurol-Urganci I;2021 [6] |
COVID-19: 369/3047 (12.1%) No COVID-19: 18,572/322,494 (5.8%) |
< 0.001# |
COVID-19: 1734/3527 (49.2%) No COVID-19:228382/338,553 (67.5%) |
< 0.001# |
COVID-19: 1355/3527 (38.4%) No COVID-19:109313/338,553 (32.3%) |
< 0.001# | — | — | — |
| Yang R;2019 [18] |
COVID-19: 9/65 (14%) No COVID-19:579/11,013 (5%) |
0.01# |
COVID-19: 13/65 (20%) No COVID-19:4993/11,013 (45%) |
— |
COVID-19: 52/65 (80%) No COVID-19:6020/11,013 (55%) |
— | < 0.001# | — | — |
| Oncel MY;2021 [7] | COVID-19: 33/125 (26.4%) | — | — | — | COVID-19: 89/125 (71.2%) | — | — | COVID-19: 6/125 (4.8%) | — |
| Al Hashmi I;2022 [8] |
COVID-19: 5/174 (2.87%) No COVID-19: 0 (0) |
0.01# | — | — |
COVID-19: 38/174(21.84%) No COVID-19: 1/87 (1.1%) |
< 0.01# | — |
COVID-19: 0/174 (0) No COVID-19:0/87 (0) |
— |
| Chung Y;2022 [9] | COVID-19: 25/65 (38.46%) | — | — | — | COVID-19: 51/65 (78.46%) | — | — | COVID-19: 0/65 (0) | — |
| Faraz S;2022 [10] | COVID-19: 57/123 (46.3%) | — | COVID-19: 61/123 (49.6%) | — | COVID-19: 62/123 (50.4%) | — | — | COVID-19: 6/123 (4.8%) | — |
| Abedzadeh-Kalahroudi M;2021 [11] | COVID-19: 11/26 (38%) | — | COVID-19: 8/26 (30.8%) | — | COVID-19: 18/26 (69.2%) | — | — | — | — |
| Al-Matary A;2021 [19] | COVID-19: 31/204 (15.5%) | — | COVID-19: 131/204 (64.2%) | — | COVID-19: 73/204 (35.8%) | — | — | COVID-19: 1/204 (0.5%) | — |
| Antoun L;2020 [12] | COVID-19: 7/19 (36.8%) | — | COVID-19: 3/19 (15.8%) | — | COVID-19: 16/19 (84%) | — | — | COVID-19: 1/19 (5.3%) | — |
| Knight M;2020 [13] | COVID-19: 70/266 (26%) | — | COVID-19: 106/262 (40.4%) | — | COVID-19: 156/262 (60%) | — | — | COVID-19: 5/427 (1%) | — |
* indicates statistical difference with p value less than 0.05; # indicates statistical difference with p value less than 0.01